Shares of Augmedix (AUGX) are up 85% at $3.34 in pre-market trading after the company announced a partnership with HCA Healthcare (HCA) to accelerate development of AI-powered technology that "aims to transform the way patient care is documented in the acute care setting".
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AUGX:
- Augmedix Blasts Up on New Partnership
- Augmedix partners with HCA Healthcare for AI-enabled documentation
- Augmedix Secures Strategic Financing from HCA Healthcare and Redmile Group
- Augmedix Announces Partnership with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation
- Augmedix price target raised to $5 from $4 at Maxim